NM_000069.3:c.1903A>G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000069.3(CACNA1S):​c.1903A>G​(p.Met635Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,601,642 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M635T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00025 ( 3 hom. )

Consequence

CACNA1S
NM_000069.3 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.564

Publications

0 publications found
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]
CACNA1S Gene-Disease associations (from GenCC):
  • hypokalemic periodic paralysis, type 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • malignant hyperthermia, susceptibility to, 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • congenital myopathy 18
    Inheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myopathy
    Inheritance: SD, AD, AR Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014149129).
BP6
Variant 1-201075540-T-C is Benign according to our data. Variant chr1-201075540-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 294753.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000172 (26/150902) while in subpopulation SAS AF = 0.000844 (4/4740). AF 95% confidence interval is 0.000288. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000069.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
NM_000069.3
MANE Select
c.1903A>Gp.Met635Val
missense
Exon 13 of 44NP_000060.2Q13698

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
ENST00000362061.4
TSL:1 MANE Select
c.1903A>Gp.Met635Val
missense
Exon 13 of 44ENSP00000355192.3Q13698
CACNA1S
ENST00000367338.7
TSL:5
c.1903A>Gp.Met635Val
missense
Exon 13 of 43ENSP00000356307.3B1ALM3
CACNA1S
ENST00000681874.1
c.1903A>Gp.Met635Val
missense
Exon 13 of 43ENSP00000505162.1A0A7P0T8M7

Frequencies

GnomAD3 genomes
AF:
0.000172
AC:
26
AN:
150780
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000844
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000517
AC:
130
AN:
251490
AF XY:
0.000589
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00764
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000105
Gnomad OTH exome
AF:
0.000814
GnomAD4 exome
AF:
0.000246
AC:
357
AN:
1450740
Hom.:
3
Cov.:
41
AF XY:
0.000315
AC XY:
227
AN XY:
721698
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33090
American (AMR)
AF:
0.00
AC:
0
AN:
44322
Ashkenazi Jewish (ASJ)
AF:
0.00732
AC:
188
AN:
25672
East Asian (EAS)
AF:
0.0000256
AC:
1
AN:
39002
South Asian (SAS)
AF:
0.00118
AC:
102
AN:
86170
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52652
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5706
European-Non Finnish (NFE)
AF:
0.0000326
AC:
36
AN:
1104604
Other (OTH)
AF:
0.000487
AC:
29
AN:
59522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000172
AC:
26
AN:
150902
Hom.:
0
Cov.:
30
AF XY:
0.000176
AC XY:
13
AN XY:
73722
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40978
American (AMR)
AF:
0.00
AC:
0
AN:
15148
Ashkenazi Jewish (ASJ)
AF:
0.00548
AC:
19
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5048
South Asian (SAS)
AF:
0.000844
AC:
4
AN:
4740
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10372
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67844
Other (OTH)
AF:
0.00
AC:
0
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000487
Hom.:
0
Bravo
AF:
0.000189
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000420
AC:
51
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
-
1
Hypokalemic periodic paralysis, type 1 (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.049
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
0.13
DANN
Benign
0.58
DEOGEN2
Uncertain
0.59
D
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.070
N
LIST_S2
Benign
0.85
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.014
T
MetaSVM
Uncertain
0.078
D
MutationAssessor
Benign
1.6
L
PhyloP100
0.56
PrimateAI
Benign
0.33
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.28
Sift
Benign
0.29
T
Sift4G
Benign
0.12
T
Polyphen
0.0
B
Vest4
0.24
MVP
0.65
MPC
0.11
ClinPred
0.013
T
GERP RS
-3.1
Varity_R
0.092
gMVP
0.49
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201784750; hg19: chr1-201044668; API